- Home
- SEDG vs ANIP Comparison
SEDG vs ANIP Comparison
Compare SEDG & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEDG
- ANIP
- Stock Information
- Founded
- SEDG 2006
- ANIP 2001
- Country
- SEDG Israel
- ANIP United States
- Employees
- SEDG N/A
- ANIP N/A
- Industry
- SEDG Semiconductors
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- SEDG Technology
- ANIP Health Care
- Exchange
- SEDG Nasdaq
- ANIP Nasdaq
- Market Cap
- SEDG 2.4B
- ANIP 2.0B
- IPO Year
- SEDG 2015
- ANIP N/A
- Fundamental
- Price
- SEDG $34.63
- ANIP $79.76
- Analyst Decision
- SEDG Sell
- ANIP Strong Buy
- Analyst Count
- SEDG 20
- ANIP 7
- Target Price
- SEDG $25.92
- ANIP $99.29
- AVG Volume (30 Days)
- SEDG 4.9M
- ANIP 498.2K
- Earning Date
- SEDG 11-05-2025
- ANIP 11-07-2025
- Dividend Yield
- SEDG N/A
- ANIP N/A
- EPS Growth
- SEDG N/A
- ANIP N/A
- EPS
- SEDG N/A
- ANIP 1.67
- Revenue
- SEDG $1,045,303,000.00
- ANIP $826,880,000.00
- Revenue This Year
- SEDG $35.00
- ANIP $40.23
- Revenue Next Year
- SEDG $16.11
- ANIP $9.65
- P/E Ratio
- SEDG N/A
- ANIP $47.66
- Revenue Growth
- SEDG 2.35
- ANIP 48.87
- 52 Week Low
- SEDG $10.41
- ANIP $52.50
- 52 Week High
- SEDG $48.60
- ANIP $99.50
- Technical
- Relative Strength Index (RSI)
- SEDG 44.96
- ANIP 28.16
- Support Level
- SEDG $32.98
- ANIP $79.39
- Resistance Level
- SEDG $37.07
- ANIP $82.12
- Average True Range (ATR)
- SEDG 4.50
- ANIP 4.36
- MACD
- SEDG -0.76
- ANIP -1.13
- Stochastic Oscillator
- SEDG 22.87
- ANIP 12.17
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.